Haemostasis

Treating rare coagulation disorders

In the field of haemostasis, LFB offers therapeutic solutions for overcoming rare coagulation disorders, which are often genetic in origin. Some patients are born with a quantitative or qualitative deficiency in coagulation factors. These are always rare diseases that need lifelong management.

One of the best known diseases in this area is haemophilia, haemophilia A (congenital factor VIII deficiency), haemophilia B (congenital factor IX deficiency) but another one is Von Willebrand disease, which is caused by a deficiency of Von Willebrand factor and affects both men and women.
The medicinal products offered by LFB in the area of haemostasis provide a response to conditions that are sometimes very rare, affecting only a few dozen patients.